Trials / Completed
CompletedNCT04005807
Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of BPN-14967 in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Belite Bio, Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is single center, randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of BPN-14967 in healthy adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BPN-14967 | BPN-14967 oral capsules |
| DRUG | Placebo | Oral capsules |
Timeline
- Start date
- 2019-07-19
- Primary completion
- 2019-12-20
- Completion
- 2019-12-20
- First posted
- 2019-07-02
- Last updated
- 2021-06-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04005807. Inclusion in this directory is not an endorsement.